MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

West Pharmaceutical Services Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

222.47 1.67

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

221.62

Max

224.25

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-40M

90M

Pardavimai

-51M

698M

P/E

Sektoriaus vid.

34.349

40.527

Pelnas, tenkantis vienai akcijai

1.45

Dividendų pajamingumas

0.38

Pelno marža

12.865

Darbuotojai

10,600

EBITDA

-54M

151M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+24.1% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.38%

2.40%

Kitas uždarbis

2025-07-24

Kitas dividendų mokėjimo data

2025-08-06

Kita Ex Dividend data

2025-07-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

370M

16B

Ankstesnė atidarymo kaina

220.8

Ankstesnė uždarymo kaina

222.47

Naujienos nuotaikos

By Acuity

50%

50%

115 / 375 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-05 04:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-07-04 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-07-04 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-07-04 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-04 20:50; UTC

Rinkos pokalbiai

Energy & Utilities Roundup: Market Talk

2025-07-04 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-07-04 16:20; UTC

Rinkos pokalbiai

Energy & Utilities Roundup: Market Talk

2025-07-04 16:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-07-04 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-04 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-07-04 15:57; UTC

Rinkos pokalbiai

Base Metal Prices Fall in Thin, Risk-off Trading -- Market Talk

2025-07-04 15:49; UTC

Rinkos pokalbiai

Gold Futures Set to End Week Flat After Mixed Jobs Report -- Market Talk

2025-07-04 15:49; UTC

Įsigijimai, susijungimai, perėmimai

Credit Agricole: Deal Will Have a Negative Impact of Approximately 30 Basis Points on the Fully-Loaded CET1 Ratio

2025-07-04 15:49; UTC

Įsigijimai, susijungimai, perėmimai

Credit Agricole: Transaction Is Consistent With Targets in Terms of Return of Investment, Return on Tangible Equity

2025-07-04 15:49; UTC

Įsigijimai, susijungimai, perėmimai

Credit Agricole Received All Required Authorizations

2025-07-04 15:48; UTC

Įsigijimai, susijungimai, perėmimai

Credit Agricole: CACEIS and Santander Are Maintaining Their Long-Term Partnership

2025-07-04 15:47; UTC

Įsigijimai, susijungimai, perėmimai

Credit Agricole: Agreement Was Announced on Dec. 19

2025-07-04 15:47; UTC

Įsigijimai, susijungimai, perėmimai

Credit Agricole Now Controls 100% of the Share Capital of CACEIS

2025-07-04 15:46; UTC

Įsigijimai, susijungimai, perėmimai

Credit Agricole Completes Acquisition of Santander's 30.5% Stake in CACEIS

2025-07-04 14:30; UTC

Įsigijimai, susijungimai, perėmimai

Rocky Shore Closes Hemlo Area Claims Sale to Barrick Mining Unit for C$975,000 Cash

2025-07-04 13:53; UTC

Rinkos pokalbiai

Polish Zloty Faces Hit From Prospect of Further Rate Cuts -- Market Talk

2025-07-04 13:41; UTC

Rinkos pokalbiai

Japanese Yen Could Receive Boost From Increased Rate-Hike Bets -- Market Talk

2025-07-04 13:41; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2025-07-04 13:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-07-04 12:37; UTC

Rinkos pokalbiai

Fund Manager Roundup: U.S. Treasurys in Focus Amid Rising Debt

2025-07-04 12:37; UTC

Rinkos pokalbiai

Fund Manager Roundup: U.S. Treasurys in Focus -2-

2025-07-04 12:30; UTC

Rinkos pokalbiai

Fund Manager Roundup: U.S. Tariff Deadline Key for Dollar Outlook, U.K. Fiscal Risks In Focus for Pound

2025-07-04 12:15; UTC

Rinkos pokalbiai

Targeted Tariffs Would Likely Support Dollar -- Market Talk

2025-07-04 12:13; UTC

Rinkos pokalbiai

Further Pause in Tariffs Would Have Unclear Impact on Dollar -- Market Talk

2025-07-04 12:02; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

West Pharmaceutical Services Inc Prognozė

Kainos tikslas

By TipRanks

24.1% į viršų

12 mėnesių prognozė

Vidutinis 275.83 USD  24.1%

Aukščiausias 325 USD

Žemiausias 245 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines West Pharmaceutical Services Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

8 ratings

7

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

213.26 / 219.27Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

115 / 375 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.